New COVID-19 drug used to treat patients suffering from respiratory failure is in trials
Fox Business Apr. 07, 2021 – 5:06 – NeuroRX CEO Dr. Jonathan Javitt discusses the new COVID-19 drug for respiratory distress and vaccine boosters.
FDA Investigating Quality Issues That Led To Millions Of J&J Vaccines To Be Thrown Out
Cheddar News – Apr 2, 2021 02:23 pm
New COVID 19 Drug can Effectively Treat Patients – Discussion with Dr. Javitt, CEO NeuroRx
Interview with Dr. Yo – Streamed live on Feb 11, 2021
Prof Jonathan Javitt joins i24NEWS – FDA Grants Continuation of COVID-19 Trial
https://www.youtube.com/watch?v=ogvdYGj5hQQ&feature=share&fbclid=IwAR33RM6pud-jcg0K5WGpDzFq27PdTcu8rYKZ_VDQagylTubUFm7aIo1UWm4
Focusing on You: UM Tests Drug to Lessen Severity of COVID-19
University of Miami Health System
UM Hospital Testing New Treatment For Patients Suffering The Worst Of COVID-19
https://www.youtube.com/watch?v=ztSFZlavXU0&feature=youtu.be
FDA advances Covid-19 therapy-Prof. Jonathan Javitt
https://www.youtube.com/watch?v=lgmpS2N8124